Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

A new mutation in the FLCN gene linked to Birt-Hogg-Dube syndrome was found, suggesting people with certain lung collapse should be tested for this mutation and screened for kidney and colon cancer.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

PTCH gene mutations contribute to basal cell carcinoma development.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

A specific mutation in Kras causes abnormal tissue changes by making a cell signal continuously active, which disrupts normal cell coordination.

Six key genes can predict bladder cancer outcomes and may serve as prognostic biomarkers.

Basal cell carcinomas need extra mutations to grow from small to large tumors.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Inactivating both p53 and Rb genes in mice speeds up aggressive skin cancer development.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

A new mutation in the CYP11B1 gene was found in a woman with mild hyperandrogenemia, a rare cause of non-classic congenital adrenal hyperplasia.

Certain genetic variations in the RAB5B gene are linked to a higher risk of polycystic ovary syndrome in Chinese Han women.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Seven new genetic risk areas for prostate cancer were found.

A woman with a new PTCH gene mutation has both Gorlin syndrome and severe hair loss.

Skin changes can indicate a risk for breast cancer.

Some Greek melanoma patients have gene mutations linked to increased cancer risk, a new color feature helps diagnose melanoma, the incidence of a skin condition in the Netherlands is rare, and a gene possibly affects male-pattern baldness.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Connexin-26 gene mutations may increase cancer risk in KID syndrome patients.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

CXCR2 in skin cells promotes tumor growth.

BAP1 mutations are rare in pediatric melanocytic tumors and may develop later in life.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

A heterozygous mutation in HTRA1 can cause severe CARASIL symptoms.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.